leadf
logo-loader
viewBioLargo, Inc.
(
OTCQB:BLGO
)

BioLargo says its PFAS water testing program has been met with 'impressive response' from customers

BioLargo, Inc's Randy Moore and Tonya Chandler joined Proactive to speak about the group's new service testing customer water to detect per- and polyfluoroalkyl substances (PFAS) contamination levels.

The group say the program offers 'peace of mind and proof of concept' to customers who need PFAS water treatment solutions in the face of an uncertain and rapidly evolving technological and regulatory landscape. From there, BioLargo’s proprietary PFAS water treatment technology, the Aqueous Electrostatic Concentrator (AEC) is deployed.

Quick facts: BioLargo, Inc.

Follow
OTCQB:BLGO

Price: 0.1875 USD

Market Cap: $42.78 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

BioLargo awarded contract at major chemical manufacturing plant for...

BioLargo (OTCQB: BLGO) CEO Dennis Calvert joined Steve Darling from Proactive Vancouver with news the company’s subsidiary BioLargo Engineering, Science & Technologies has been awarded a contract to assist in the reconfiguration of the Regenerative Thermal Oxidizer systems used at a large...

on 23/10/20

2 min read